JHS Sven.Lab.

{
  "main_header": {
    "sid": 150728,
    "name": "JHS Sven.Lab.",
    "stock_name": "JHS Sven.Lab.",
    "full_name": "JHS Svendgaard Laboratories Ltd",
    "name_url": "stocks-analysis/jhs-svenlab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "10.50",
    "chg": -0.66,
    "chgp": "-5.91%",
    "dir": -1,
    "prev_price": "11.16",
    "mcapval": "99.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532771,
    "symbol": "JHS",
    "ind_name": "FMCG",
    "ind_code": 31,
    "indexname": "",
    "isin": "INE544H01014",
    "curr_date": "Feb 12",
    "curr_time": "",
    "bse_nse_vol": "1.57 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 12, 2026",
    "traded_date_str": "2026 02 12",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/jhs-svenlab-150728-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Are JHS Svendgaard Laboratories Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-jhs-svendgaard-laboratories-ltd-latest-results-good-or-bad-3833347",
        "imagepath": "",
        "date": "2026-02-11 19:26:22",
        "description": "The latest financial results for JHS Svendgaard Laboratories Ltd present a mixed picture of operational performance. In Q2 FY26, the company reported net sales of ₹22.28 crores, reflecting a year-on-year growth of 13.21% compared to ₹19.68 crores in Q2 FY25. However, this growth was accompanied by a net loss of ₹0.20 crores, a significant decline from the profit of ₹1.06 crores recorded in the previous quarter. This return to losses highlights ongoing challenges in achieving consistent profitability.\n\nOperating margins also showed a decline, with the operating profit margin falling to 4.08% from 7.08% in Q1 FY26. This contraction suggests potential issues such as increased costs or operational inefficiencies. Additionally, the profit after tax (PAT) margin turned negative at -0.90%, indicating further deterioration in financial performance.\n\nDespite the revenue growth, the company has faced chronic profitab..."
      },
      {
        "title": "JHS Svendgaard Q3 FY26: Profitability Remains Elusive Amid Revenue Growth",
        "link": "https://www.marketsmojo.com/news/result-analysis/jhs-svendgaard-q3-fy26-profitability-remains-elusive-amid-revenue-growth-3831709",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/JHSSvendgaardLa_quaterlyResult_3831709.png",
        "date": "2026-02-10 20:01:07",
        "description": "JHS Svendgaard Laboratories Ltd., a micro-cap oral care products manufacturer, reported a net loss of ₹0.20 crores in Q2 FY26 (Jul-Sep'25), reversing from a profit of ₹1.06 crores in the previous quarter. The company's stock, currently trading at ₹10.80, has declined 2.96% following the results announcement and remains down 40.46% over the past year, significantly underperforming the FMCG sector's 4.92% gain. With a market capitalisation of just ₹99.00 crores and a troubling financial track record, the Himachal Pradesh-based manufacturer faces mounting challenges in restoring investor confidence."
      },
      {
        "title": "Are JHS Svendgaard Laboratories Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-jhs-svendgaard-laboratories-ltd-latest-results-good-or-bad-3831457",
        "imagepath": "",
        "date": "2026-02-10 19:23:06",
        "description": "The latest financial results for JHS Svendgaard Laboratories Ltd highlight a company grappling with significant operational challenges. In the quarter ended September 2025, the company reported net sales of ₹22.28 crores, reflecting a sequential decline of 4.99% from the previous quarter, although it did show a year-on-year growth of 13.21% compared to ₹19.68 crores in the same quarter last year. This mixed performance suggests that while there may be some seasonal demand, it does not indicate a sustainable growth trajectory.\n\nThe operating margin for the quarter was reported at 4.08%, a notable reduction from 7.08% in the previous quarter, indicating pressure on profitability. Furthermore, the company recorded a net loss of ₹0.20 crores, marking a significant reversal from the profit of ₹1.06 crores reported in the prior quarter. This loss underscores the ongoing difficulty in achieving consistent profitab..."
      },
      {
        "title": "JHS Svendgaard Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jhs-svendgaard-laboratories-ltd-is-rated-strong-sell-3830547",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/JHSSvendgaardLa_mojoScore_3830547.png",
        "date": "2026-02-10 10:10:07",
        "description": "JHS Svendgaard Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 November 2024. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 10 February 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "When is the next results date for JHS Svendgaard Laboratories Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-jhs-svendgaard-laboratories-ltd-3823088",
        "imagepath": "",
        "date": "2026-02-05 23:16:58",
        "description": "The next results date for JHS Svendgaard Laboratories Ltd is scheduled for 10 February 2026...."
      },
      {
        "title": "JHS Svendgaard Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jhs-svendgaard-laboratories-ltd-is-rated-strong-sell-3811115",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/JHSSvendgaardLa_mojoScore_3811115.png",
        "date": "2026-01-30 10:10:35",
        "description": "JHS Svendgaard Laboratories Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 13 November 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 January 2026, providing investors with an up-to-date view of the company's performance and outlook."
      },
      {
        "title": "JHS Svendgaard Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jhs-svendgaard-laboratories-ltd-is-rated-strong-sell-3794047",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/JHSSvendgaardLa_mojoScore_3794047.png",
        "date": "2026-01-19 10:10:18",
        "description": "JHS Svendgaard Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 Nov 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 19 January 2026, providing investors with an up-to-date view of its fundamentals, returns, and market performance."
      },
      {
        "title": "JHS Svendgaard Laboratories Ltd Hits 52-Week Low Amidst Continued Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jhs-svendgaard-laboratories-ltd-hits-52-week-low-amidst-continued-underperformance-3784100",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/JHSSvendgaardLa_priceRelatedfactors_3784100.png",
        "date": "2026-01-07 09:41:23",
        "description": "JHS Svendgaard Laboratories Ltd, a player in the FMCG sector, recorded a new 52-week low of Rs.8.97 today, marking a significant decline in its stock price amid ongoing market pressures and company-specific challenges."
      },
      {
        "title": "JHS Svendgaard Laboratories Ltd Falls to 52-Week Low of Rs.9.04",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jhs-svendgaard-laboratories-ltd-falls-to-52-week-low-of-rs904-3783368",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/JHSSvendgaardLa_priceRelatedfactors_3783368.png",
        "date": "2026-01-06 11:10:05",
        "description": "JHS Svendgaard Laboratories Ltd has touched a fresh 52-week low of Rs.9.04 today, marking a significant decline in its share price amid a sustained downward trend over recent sessions. The stock has underperformed its sector and broader market indices, reflecting ongoing concerns about its financial health and market positioning."
      }
    ],
    "total": 185,
    "sid": "150728",
    "stock_news_url": "https://www.marketsmojo.com/news/jhs-svendgaard-laboratories-150728"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Un-Audited Financial Results For The Quarter And Nine Month Ended 31St December 2025",
      "datetime": "10-Feb-2026",
      "details": "To considered and approved the Un-Audited Financial Results for the Quarter and Nine Month Ended 31st December 2025",
      "source": "BSE"
    },
    {
      "caption": "Intimation Of Grant Of ESOP",
      "datetime": "10-Feb-2026",
      "details": "Intimation of Grant of ESOP under JHS Svendgaard Laboratories Limited Employee Option Scheme 2025.",
      "source": "BSE"
    },
    {
      "caption": "Un- Audited Financial Result For The Quarter Ended 31St December 2025",
      "datetime": "10-Feb-2026",
      "details": "The Board of Director Considered and approved the Un-Audited Financial Results for the Quarter Ended 31st December 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "JHS Svendgaard Laboratories Ltd has declared <strong>8%</strong> dividend, ex-date: 26 Dec 11",
          "dt": "2011-12-26",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Are JHS Svendgaard Laboratories Ltd latest results good or bad?

2026-02-11 19:26:22

The latest financial results for JHS Svendgaard Laboratories Ltd present a mixed picture of operational performance. In Q2 FY26, the company reported net sales of ₹22.28 crores, reflecting a year-on-year growth of 13.21% compared to ₹19.68 crores in Q2 FY25. However, this growth was accompanied by a net loss of ₹0.20 crores, a significant decline from the profit of ₹1.06 crores recorded in the previous quarter. This return to losses highlights ongoing challenges in achieving consistent profitability. Operating margins also showed a decline, with the operating profit margin falling to 4.08% from 7.08% in Q1 FY26. This contraction suggests potential issues such as increased costs or operational inefficiencies. Additionally, the profit after tax (PAT) margin turned negative at -0.90%, indicating further deterioration in financial performance. Despite the revenue growth, the company has faced chronic profitab...

Read full news article

JHS Svendgaard Q3 FY26: Profitability Remains Elusive Amid Revenue Growth

2026-02-10 20:01:07

JHS Svendgaard Laboratories Ltd., a micro-cap oral care products manufacturer, reported a net loss of ₹0.20 crores in Q2 FY26 (Jul-Sep'25), reversing from a profit of ₹1.06 crores in the previous quarter. The company's stock, currently trading at ₹10.80, has declined 2.96% following the results announcement and remains down 40.46% over the past year, significantly underperforming the FMCG sector's 4.92% gain. With a market capitalisation of just ₹99.00 crores and a troubling financial track record, the Himachal Pradesh-based manufacturer faces mounting challenges in restoring investor confidence.

Read full news article

Are JHS Svendgaard Laboratories Ltd latest results good or bad?

2026-02-10 19:23:06

The latest financial results for JHS Svendgaard Laboratories Ltd highlight a company grappling with significant operational challenges. In the quarter ended September 2025, the company reported net sales of ₹22.28 crores, reflecting a sequential decline of 4.99% from the previous quarter, although it did show a year-on-year growth of 13.21% compared to ₹19.68 crores in the same quarter last year. This mixed performance suggests that while there may be some seasonal demand, it does not indicate a sustainable growth trajectory. The operating margin for the quarter was reported at 4.08%, a notable reduction from 7.08% in the previous quarter, indicating pressure on profitability. Furthermore, the company recorded a net loss of ₹0.20 crores, marking a significant reversal from the profit of ₹1.06 crores reported in the prior quarter. This loss underscores the ongoing difficulty in achieving consistent profitab...

Read full news article

JHS Svendgaard Laboratories Ltd is Rated Strong Sell

2026-02-10 10:10:07

JHS Svendgaard Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 November 2024. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 10 February 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

When is the next results date for JHS Svendgaard Laboratories Ltd?

2026-02-05 23:16:58

The next results date for JHS Svendgaard Laboratories Ltd is scheduled for 10 February 2026....

Read full news article

JHS Svendgaard Laboratories Ltd is Rated Strong Sell

2026-01-30 10:10:35

JHS Svendgaard Laboratories Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 13 November 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 January 2026, providing investors with an up-to-date view of the company's performance and outlook.

Read full news article

JHS Svendgaard Laboratories Ltd is Rated Strong Sell

2026-01-19 10:10:18

JHS Svendgaard Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 Nov 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 19 January 2026, providing investors with an up-to-date view of its fundamentals, returns, and market performance.

Read full news article

JHS Svendgaard Laboratories Ltd Hits 52-Week Low Amidst Continued Underperformance

2026-01-07 09:41:23

JHS Svendgaard Laboratories Ltd, a player in the FMCG sector, recorded a new 52-week low of Rs.8.97 today, marking a significant decline in its stock price amid ongoing market pressures and company-specific challenges.

Read full news article

JHS Svendgaard Laboratories Ltd Falls to 52-Week Low of Rs.9.04

2026-01-06 11:10:05

JHS Svendgaard Laboratories Ltd has touched a fresh 52-week low of Rs.9.04 today, marking a significant decline in its share price amid a sustained downward trend over recent sessions. The stock has underperformed its sector and broader market indices, reflecting ongoing concerns about its financial health and market positioning.

Read full news article

View All News